US 6537804
BCR-ABL directed compositions and uses for inhibiting Philadelphia chromesome stimulated cell growth
expired A61KA61K38/00A61P
Quick answer
US patent 6537804 (BCR-ABL directed compositions and uses for inhibiting Philadelphia chromesome stimulated cell growth) held by The Board of Regents of the University of Texas System expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K38/00, A61P, A61P31/12